Data / Drug companies / Ascent Pharmaceuticals, Inc.
Ascent Pharmaceuticals, Inc.: 17 products in the FDA NDC directory, labeler code 43602
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Ascent Pharmaceuticals, Inc. (labeler code 43602) lists 17 products in the FDA National Drug Code Directory, covering 7 finished drugs by generic name. By type: 15 prescription drugs, 2 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on July 15, 2025.
The request: Watch Ascent Pharmaceuticals, Inc. (FDA labeler code 43602): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 43602
- Products in commercial distribution
- 17
- Packages
- 34
- Finished drugs by generic name
- 7
- Prescription products
- 15
- Over the counter products
- 2
- Controlled substance products
- Schedule II 8
- Flagged as original packager
- 17 of 17 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- July 13, 2017
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 17 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 15 | 88.2% |
| Over the counter drugs | 2 | 11.8% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Hydromorphone hydrochloride | 4 | 20 |
| Sertraline hydrochloride | 3 | 55 |
| Escitalopram | 3 | 34 |
| Methylphenidate hydrochloride | 2 | 39 |
| Oxycodone hydrochloride | 2 | 36 |
| Famotidine | 2 | 138 |
| Ibuprofen and famotidine | 1 | 14 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 12 | 70.6% |
| Solution | 5 | 29.4% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Serotonin Reuptake Inhibitor | 6 |
| Opioid Agonist | 6 |
| Histamine-2 Receptor Antagonist | 3 |
| Central Nervous System Stimulant | 2 |
| Nonsteroidal Anti-inflammatory Drug | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Escitalopram oxalate | 43602-475 | Tablet | Generic drugs (ANDA) | July 15, 2025 |
| Escitalopram oxalate | 43602-474 | Tablet | Generic drugs (ANDA) | July 15, 2025 |
| Escitalopram oxalate | 43602-473 | Tablet | Generic drugs (ANDA) | July 15, 2025 |
| Ibuprofen and famotidine | 43602-544 | Tablet | Generic drugs (ANDA) | October 6, 2022 |
| Famotidine | 43602-602 | Tablet | Generic drugs (ANDA) | November 3, 2021 |
| Famotidine | 43602-511 | Tablet | Generic drugs (ANDA) | November 3, 2021 |
| Sertraline hydrochloride | 43602-981 | Tablet | Generic drugs (ANDA) | May 3, 2021 |
| Sertraline hydrochloride | 43602-980 | Tablet | Generic drugs (ANDA) | May 3, 2021 |
| Sertraline hydrochloride | 43602-979 | Tablet | Generic drugs (ANDA) | May 3, 2021 |
| Methylphenidate Hydrochloride | 43602-178 | Solution | Generic drugs (ANDA) | January 29, 2021 |
| Methylphenidate Hydrochloride | 43602-177 | Solution | Generic drugs (ANDA) | January 29, 2021 |
| Hydromorphone Hydrochloride | 43602-001 | Solution | Generic drugs (ANDA) | May 4, 2019 |
| Hydromorphone hydrochloride | 43602-004 | Tablet | Generic drugs (ANDA) | January 24, 2018 |
| Hydromorphone hydrochloride | 43602-003 | Tablet | Generic drugs (ANDA) | January 24, 2018 |
| Hydromorphone hydrochloride | 43602-002 | Tablet | Generic drugs (ANDA) | January 24, 2018 |
| Oxycodone hydrochloride | 43602-198 | Solution | Generic drugs (ANDA) | July 13, 2017 |
| Oxycodone hydrochloride | 43602-190 | Solution | Generic drugs (ANDA) | July 13, 2017 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.